STOCK TITAN

Microchip Technology Inc. 10-Q Filings

MCHP NASDAQ

Every 10-Q that Microchip Technology Inc. (MCHP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow MCHP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MCHP filings page.

Rhea-AI Summary

Microchip Technology Incorporated generated $1,484.7 million in net sales for the quarter ended June 30, 2026, up 38% year over year, and earned net income of $229.8 million. Net income attributable to common stockholders was $202.0 million, or $0.37 per diluted share.

Gross margin expanded to 63.2% from 53.6%, helped by product mix, lower underutilization charges, reduced inventory reserves and higher licensing revenue. Operating cash flow was $511.5 million, funding common dividends of $0.455 per share and preferred dividends, while inventory days decreased to 175.

Long-term debt totaled $5,361.3 million with no borrowings on the revolving credit facility and $211.0 million of Commercial Paper outstanding. Management also describes a Malaysian tax dispute that could expose the company to up to $474.7 million in taxes and penalties if resolved adversely.

Rhea-AI Summary

Microchip Technology Incorporated reported stronger results for the quarter ended December 31, 2025. Net sales rose to $1,186.0 million from $1,026.0 million a year earlier, and net income improved to $62.7 million from a net loss of $53.6 million.

For the first nine months, net sales were $3,401.9 million versus $3,431.1 million, with net income of $85.8 million compared to $154.1 million. Operating cash flow was $705.1 million, supporting $737.4 million of common dividends and $80.7 million of preferred dividends.

Debt remained significant with $5,366.0 million of net long-term debt, including $1,106.0 million of commercial paper and multiple senior notes and convertible debt series. Deferred revenue totaled $345.0 million, much of it tied to long-term supply agreements that provide assured capacity to customers over several years.

Rhea-AI Summary

Microchip Technology (MCHP) filed its quarterly report for the period ended September 30, 2025. Net sales were $1,140.4 million versus $1,163.8 million a year ago, with gross profit of $637.9 million. Operating income was $88.9 million, down from $146.6 million. Net income was $41.7 million; after $27.8 million of Series A preferred dividends, net income attributable to common stockholders was $13.9 million, or $0.03 per diluted share, versus $0.14 a year ago.

For the first six months, net sales were $2,215.9 million versus $2,405.1 million, and operating income was $121.0 million versus $365.7 million. Operating cash flow was $363.7 million. Cash and cash equivalents were $236.8 million, down from $771.7 million at March 31, 2025. The company settled $1.2 billion of 4.250% 2025 notes in September using Commercial Paper and cash; Commercial Paper outstanding was $1.12 billion. Deferred revenue was $385.8 million, including $291.5 million of LTSA deposits. The company paid a $0.455 per‑share common dividend and $27.8 million on its 7.50% Series A preferred, and disclosed an IRS settlement for fiscal years 2007–2015.